Adlai Nortye is a biopharmaceutical company discovering, developing and commercializing new drugs for cancer and metabolic diseases.
Agios works on cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic diseases and metabolic immuno-oncology.
Akero Therapeutics is providing treatment options for people with serious metabolic diseases like non-alcoholic steatohepatitis (NASH), a disease marked by inflammation in the liver and liver cell ...
acute and chronic aldehyde metabolism disorders
Axcella is combining endogenous metabolic modulators to develop powerful new medicines with the goal of addressing metabolic dysregulation
Weight loss device
Contract research services in pharmacokinetics, toxicology, oncology, metabolic diseases, wound healing, and animal model development.
Inozyme Pharma is focused on developing treatments for rare and debilitating metabolic diseases, with an initial focus on disorders of pyrophosphate deficiency.
The Kyn Therapeutics pipeline addresses distinct immuno-metabolic targets. Each of these programs targets key metabolites in highly characterized pathways that drive immunosuppression in numerous ...
Diagnostics & Services
NeuroPointDX, through its compound safety screening division Stemina Biomarker Discovery, has developed the leading metabolomics platform for ...
Nightingale’s platform makes comprehensive biomarker profiling affordable for biobanks and cohorts of any scale. The platform provides over 220 biomarkers in a single experiment. Amino acids, ...
Drugs for metabolic disease
Develops therapeutics to treat metabolic disorders related to circadian rhythm dysfunction and narcolepsy.
Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain.